{"product_id":"in-silico-technologies-in-drug-target-identification-and-validation-9781574444780","title":"In Silico Technologies in Drug Target Identification and Validation","description":"\u003cp\u003e • Author(s): Darryl Leon | Scott Markel\u003cbr\u003e • Publisher: CRC Press\u003cbr\u003e • Publisher Imprint: CRC Press\u003cbr\u003e • BISAC: Pharmacology\u003c\/p\u003e\u003cp\u003e\u003c\/p\u003e\u003cp\u003eThe pharmaceutical industry relies on numerous well-designed experiments involving high-throughput techniques and \u003ci\u003ein silico\u003c\/i\u003e approaches to analyze potential drug targets. These \u003ci\u003ein silico\u003c\/i\u003e methods are often predictive, yielding faster and less expensive analyses than traditional \u003ci\u003ein vivo\u003c\/i\u003e or \u003ci\u003ein vitro\u003c\/i\u003e procedures.\u003c\/p\u003e\u003cp\u003e\u003cb\u003e\u003ci\u003eIn Silico\u003c\/i\u003e\u003c\/b\u003e\u003cb\u003e Technologies in Drug Target Identification and Validation \u003c\/b\u003eaddresses the challenge of testing a growing number of new potential targets and reviews currently available \u003ci\u003ein silico\u003c\/i\u003e approaches for identifying and validating these targets. The book emphasizes computational tools, public and commercial databases, mathematical methods, and software for interpreting complex experimental data. The book describes how these tools are used to visualize a target structure, identify binding sites, and predict behavior. World-renowned researchers cover many topics not typically found in most informatics books, including functional annotation, siRNA design, pathways, text mining, ontologies, systems biology, database management, data pipelining, and pharmacogenomics. \u003c\/p\u003e\u003cp\u003eCovering issues that range from prescreening target selection to genetic modeling and valuable data integration, \u003cb\u003e\u003ci\u003e In Silico\u003c\/i\u003e Technologies in Drug Target Identification and Validation\u003c\/b\u003e is a self-contained and practical guide to the various computational tools that can accelerate the identification and validation stages of drug target discovery and determine the biological functionality of potential targets more effectively. \u003c\/p\u003e\u003cp\u003eDaniel E. Levy, editor of the \u003cem\u003eDrug Discovery Series\u003c\/em\u003e, is the founder of DEL BioPharma, a consulting service for drug discovery programs. He also maintains a blog that explores organic chemistry.\u003c\/p\u003e","brand":"CRC Press","offers":[{"title":"Hardcover","offer_id":46931791610007,"sku":"9781574444780","price":16540.0,"currency_code":"INR","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0666\/3471\/1191\/files\/9781574444780.webp?v=1771616180","url":"https:\/\/atlanticbooks.com\/products\/in-silico-technologies-in-drug-target-identification-and-validation-9781574444780","provider":"Atlantic Books","version":"1.0","type":"link"}